Centogene

CENTOGENE is a world leader in the field of genetic diagnostics for rare diseases dedicated to improve patients' lives every day.

CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.

- Has been assisting in diagnosing with rare and neurodegenerative disorders globally for more than 15 years. 
Large amounts of genomic and phenotypic information as well as patient samples are documented and stored securely in CENTOGENE’s Biodatabank.

- Has logistic and diagnostic solutions that enable state-of-the-art genetic and biochemical analysis for new patients and is experienced in conducting clinical trial testing, applying GCLP.

- Follows the strictest quality criteria as a CAP accredited, CLIA certified laboratory that receives samples globally and processes the data in a GDPR compliant way.